📈U.S. Trade Investigation into Brazil's Unfair Practices
In accordance with the specific direction of the President, on July 15, 2025 the U.S. Trade Representative initiated an investigation into Brazil's acts, policies, and practices related to digital trade and electronic payment services; unfair, preferential tariffs; anti- corruption enforcement; intellectual property protection; ethanol market access; and illegal deforestation. The Section 301 Committee is holding a public hearing and seeking public comments in connection with this investigation.
Learn More🔊ITC Notice on Sonos vs. Google Patent Determination
Notice is hereby given that the U.S. International Trade Commission ("Commission") has determined to adopt an initial determination ("ID") (Order No. 39) issued by the presiding administrative law judge ("ALJ") granting respondent's motion for summary determination of invalidity of the asserted patent claims due to indefiniteness. The Commission previously vacated the ID's termination for "good cause." The investigation is terminated with a finding of no violation of section 337.
Learn More🚀NASA's Notice to Grant Patent License
NASA hereby gives notice of its intent to grant an exclusive, co-exclusive or partially exclusive patent license to practice the inventions described and claimed in the patents and/or patent applications listed in SUPPLEMENTARY INFORMATION below.
Learn More🚀NASA's Notice of Intent to Grant Exclusive Patent Licenses
NASA hereby gives notice of its intent to grant an exclusive, co-exclusive or partially exclusive patent license to practice the inventions described and claimed in the patents and/or patent applications listed in SUPPLEMENTARY INFORMATION below.
Learn More💉NIH Proposes New Intellectual Property Policy for Cancer Research
The National Cancer Institute, an Institute of the National Institutes of Health, Department of Health and Human Services, Division of Cancer Prevention (DCP) is seeking comments on instituting a standard policy on Intellectual Property (IP) developed by certain funding recipients under NCI DCP funding agreements. This standard policy is entitled "The DIVISION OF CANCER PREVENTION INTELLECTUAL PROPERTY OPTION TO COLLABORATORS (IP Option)." The proposed policy, if finalized, shall apply to entities that conduct DCP-funded clinical studies under funding agreements which involve an NCI collaborator that provides its proprietary agent or technology for the DCP-supported studies where this IP Option is included as a term of applicable existing and future funding agreements.
Learn More🧬Requirements for Patent Applications with Nucleotide Sequence Disclosures
The United States Patent and Trademark Office (USPTO), as required by the Paperwork Reduction Act of 1995, invites comments on the extension and revision of an existing information collection: 0651- 0024 (Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures). The purpose of this notice is to allow 60 days for public comments preceding submission of the information collection to the Office of Management and Budget (OMB).
Learn More📄Business Implications of the Patent Cooperation Treaty Information Collection
The United States Patent and Trademark Office (USPTO), as required by the Paperwork Reduction Act of 1995, invites comments on the extension and revision of an existing information collection: 0651- 0021 (Patent Cooperation Treaty). The purpose of this notice is to allow 60 days for public comments preceding submission of the information collection to the Office of Management and Budget (OMB).
Learn More📦ITC Decision on OLED Display Modules and Trade Secret Investigation
Notice is hereby given that the U.S. International Trade Commission ("Commission") has determined not to review an initial determination ("ID") (Order No. 63) of the presiding administrative law judge ("ALJ"), to amend the complaint and notice of investigation to change the name of one of the respondents.
Learn More📄NASA Notice
NASA hereby gives notice of its intent to grant an exclusive, co-exclusive or partially exclusive patent license to practice the inventions described and claimed in the patents and/or patent applications listed in SUPPLEMENTARY INFORMATION below.
Learn More📑Exclusive Patent License Notice for Intuidex, Inc.
Pursuant to the Bayh-Dole Act and implementing regulations, the Department of the Air Force hereby gives notice of its intent to grant an exclusive patent license to Intuidex, Inc. duly organized, validly existing, and in good standing in the State of Wyoming having a place of business at 1892 Mill Run CT, Hellertown, PA 18055.
Learn More